Aristides Capital »

Phathom Pharmaceuticals shares owned by Aristides Capital

Quarter-by-quarter ownership of Phathom Pharmaceuticals (PHAT) shares owned by Aristides Capital from 13F filings

Historical chart of Aristides Capital investment in Phathom Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Phathom Pharmaceuticals held by Aristides Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Phathom Pharmaceuticals by Aristides Capital

Quarter filed Position value Share count Share price at filing
2024-12-31 $205k 25k 8.12

More positions owned by Aristides Capital

Tesla Put Put Option
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Bitcoin Trust Etf Call Call Option
Ishares Bitcoin Trust Etf Put Put Option
Rigetti Computing Put Put Option
Ionq Put Put Option
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Ark Etf Tr Call Call Option
Quantum Computing Put Put Option
Alphabet Cap Stk Cl A (GOOGL)
Carvana Put Put Option
California Res Corp Com Stock (CRC)
Ituran Location And Control SHS (ITRN)
D-wave Quantum Put Put Option
Strategy Put Put Option

View all positions for Aristides Capital

Top funds holding Phathom Pharmaceuticals

Frazier Life Sciences Management
Medicxi Ventures Management
Millennium Management
Invesco
Carlyle
BlackRock
Vanguard Group
Ensign Peak Advisors
NEA Management Company
683 Capital Management
Daniel D. Thurber
Catalys Pacific
Jennifer Ranahan
Catalio Capital Management
Geode Capital Management

View all funds holding Phathom Pharmaceuticals